MedPlus subsidiary Optival Health received one-day drug license suspension for Delhi store.
Violation cited under Rule 65 of Drugs and Cosmetics Act, 1940 and Rules, 1945.
Potential revenue loss quantified at ₹0.30 lakhs from the one-day suspension.
Disclosure made pursuant to SEBI Listing Regulations circulars dated 2023 and 2024.